L

Longeveron
D

LGVN

2.18000
USD
-0.08
(-3.54%)
Market Open
Volume
2,795
EPS
0
Div Yield
0
P/E
-0
Market Cap
31,303,662
OverviewSignalsIdeasNews
Related Instruments
    C
    CRS
    -1.880
    (-1.29%)
    144.050 USD
    D
    DOCU
    -1.870
    (-3.37%)
    53.600 USD
    EMR
    -4.010
    (-3.42%)
    113.080 USD
    F
    FENG
    -0.06000
    (-1.66%)
    3.56000 USD
    O
    OSH
    0
    (0%)
    0.000000 USD
    R
    RMBS
    -6.530
    (-12.69%)
    44.910 USD
    S
    SPSC
    -6.610
    (-3.07%)
    208.920 USD
News

Title: Longeveron

Sector: Healthcare
Industry: Biotechnology
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.